Burden of illness of hypertension among women using menopausal hormone therapy: a US perspective

References

• Schulman IH, Aranda P, Raij L, et al. Surgical menopause increases salt sensitivity of blood pressure. Hypertension 2006;47:1168-74
   PubMed Web of Science ®Google Scholar
• Wassertheil-Smoller S, Anderson G, Psaty BM, et al. Hypertension and its treatment in postmenopausal women: baseline data from the Women’s Health Initiative. Hypertension 2000;36:780-9
   PubMed Web of Science ®Google Scholar
• Preston RA. Effects of blood pressure reduction on cardiovascular risk estimates in hypertensive postmenopausal women. Climacteric 2007;10(Suppl 1):32-41
   PubMedGoogle Scholar
• Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-13
   PubMed Web of Science ®Google Scholar
• Fields LE, Burt VL, Cutler JA, et al. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 2004;44:398-404
   PubMed Web of Science ®Google Scholar
• Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290:199-206
   PubMed Web of Science ®Google Scholar
• August P, Oparil S. Hypertension in women. J Clin Endocrinol Metab 2000;84:1862-6
   Web of Science ®Google Scholar
• McCubbin JA, Helfer SG, Switzer FS III, et al. Blood pressure control and hormone replacement therapy in postmenopausal women at risk for coronary heart disease. Am Heart J 2002;143:711-17
   PubMed Web of Science ®Google Scholar
• Wyss JM, Carlson SH. Effects of hormone replacement therapy on the sympathetic nervous system and blood pressure. Curr Hypertens Rep 2003;5:241-6
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52
   PubMed Web of Science ®Google Scholar
• Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004;291:47-53
   PubMed Web of Science ®Google Scholar
• Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321-33
   PubMed Web of Science ®Google Scholar
• Ravdin PM, Cronin KA, Howlader N, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 2007;356:1670-4
   PubMed Web of Science ®Google Scholar
• Hing E, Brett KM. Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003. Obstet Gynecol 2006;108:33-40
   PubMed Web of Science ®Google Scholar
• Buist DS, Newton KM, Miglioretti DL, et al. Hormone therapy prescribing patterns in the United States. Obstet Gynecol 2004;104:1042-50
   PubMed Web of Science ®Google Scholar
• Brett, KM, Chong Y. Hormone Replacement Therapy: Knowledge and Use in the United States. 2001. Hyattsville, MD, National Center for Health Statistics
   Google Scholar
• Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol 1997;145:536-45
   PubMed Web of Science ®Google Scholar
• Mills PJ, Farag NH, Matthews S, et al. Hormone replacement therapy does not affect 24-h ambulatory blood pressure in healthy non-smoking postmenopausal women. Blood Press Monit 2003;8:57-61
   PubMed Web of Science ®Google Scholar
• The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995;273:199-208
   PubMed Web of Science ®Google Scholar
• Sharma AM, Homuth V, Luft FC. Hormone replacement therapy and blood pressure in normotensive and hypertensive women. Nephrol Dial Transplant 2001;16:888-90
   PubMed Web of Science ®Google Scholar
• Kawecka-Jaszcz K, Czarnecka D, Olszanecka A, et al. The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension. J Hum Hypertens 2002;16:509-16
   PubMed Web of Science ®Google Scholar
• Enstrom I, Lidfeldt J, Lindholm LH, et al. Does blood pressure differ between users and non-users of hormone replacement therapy? The Women’s Health in the Lund Area (WHILA) Study. Blood Press 2002;11:240-3
   PubMed Web of Science ®Google Scholar
• Czarnecka D, Kawecka-Jaszcz K, Olszanecka A, et al. The effect of hormone replacement therapy on endothelial function in postmenopausal women with hypertension. Med Sci Monit 2004;10:CR55-61
   PubMed Web of Science ®Google Scholar
• Lip GY, Beevers M, Churchill D, et al. Hormone replacement therapy and blood pressure in hypertensive women. J Hum Hypertens 1994;8:491-4
   PubMed Web of Science ®Google Scholar
• Butkevich A, Abraham C, Phillips RA. Hormone replacement therapy and 24-hour blood pressure profile of postmenopausal women. Am J Hypertens 2000;13:1039-41
   PubMed Web of Science ®Google Scholar
• Cacciatore B, Paakkari I, Hasselblatt R, et al. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women. Am J Obstet Gynecol 2001;184:904-9
   PubMed Web of Science ®Google Scholar
• Wong J, Wong S, Handa P, et al. Hormone replacement use, arterial distensibility, cardiac structure and circadian blood pressure profile in menopausal women. Blood Press 2005;14:12-20
   PubMed Web of Science ®Google Scholar
• Mercuro G, Zoncu S, Piano D, et al. Estradiol-17 beta reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertension. Am J Hypertens 1998;11:909-13
   PubMed Web of Science ®Google Scholar
• Kaya C, Dincer CS, Cengiz B, et al. The long-term effects of low-dose 17beta-estradiol and dydrogesterone hormone replacement therapy on 24-h ambulatory blood pressure in hypertensive postmenopausal women: a 1-year randomized, prospective study. Climacteric 2006;9:437-45
   PubMed Web of Science ®Google Scholar
• Christ M, Seyffart K, Tillmann HC, et al. Hormone replacement in postmenopausal women: impact of progestogens on autonomic tone and blood pressure regulation. Menopause 2002;9:127-36
   PubMed Web of Science ®Google Scholar
• Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA 2004;291:1701-12
   PubMed Web of Science ®Google Scholar
• Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523-34
   PubMed Web of Science ®Google Scholar
• Steiner AZ, Hodis HN, Lobo RA, et al. Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial. Menopause 2005;12:728-33
   PubMed Web of Science ®Google Scholar
• Balu S, Thomas J, III Incremental expenditure of treating hypertension in the United States. Am J Hypertens 2006;19:810-16
   PubMed Web of Science ®Google Scholar
• Hodgson TA, Cai L. Medical care expenditures for hypertension, its complications, and its comorbidities. Med Care 2001;39:599-615
   PubMed Web of Science ®Google Scholar
• Odell TW, Gregory MC. Cost of hypertension treatment. J Gen Intern Med 1995;10:686-8
   PubMed Web of Science ®Google Scholar
• Utian WH. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. Health Qual Life Outcomes 2005;3:47
   PubMedGoogle Scholar
• Botteman MF, Shah NP, Lian J, et al. A cost-effectiveness evaluation of two continuous-combined hormone therapies for the management of moderate-to-severe vasomotor symptoms. Menopause 2004;11:343-55
   PubMed Web of Science ®Google Scholar
• Ohsfeldt RL, Gavin NI, Thorp JM. Medical care costs associated with postmenopausal estrogen plus progestogen therapy. Value Health 2004;7:544-53
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83
   PubMedGoogle Scholar
• D’Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol 1996;49:1429-33
   PubMed Web of Science ®Google Scholar
• Baser O. Too much ado about propensity score models? Comparing methods of propensity score matching. Value Health 2006;9:377-85
   PubMed Web of Science ®Google Scholar
• Ganguly R, Martin B, Dorfman J. In search of an unbiased estimate of treatment effect using observational data: a comparison of propensity scoring and Heckman two stage sample selection models. ISPOR Connections 2004;10:2-5
   Google Scholar
• Ozminkowski RJ, Burton WN, Goetzel RZ, et al. The impact of rheumatoid arthritis on medical expenditures, absenteeism, and short-term disability benefits. J Occup Environ Med 2006;48:135-48
   PubMed Web of Science ®Google Scholar
• Goodman SN. Toward evidence-based medical statistics. 1: The P value fallacy. Ann Intern Med 1999;130:995-1004
   PubMed Web of Science ®Google Scholar
• Hawkins K, Wang S, Rupnow M. Direct cost burden among insured US employees with migraine. Headache 2008;48:553-63
   PubMed Web of Science ®Google Scholar
• Lipton RB, Bigal ME. Migraine: epidemiology, impact, and risk factors for progression. Headache 2005;45(Suppl 1):S3-13
   PubMed Web of Science ®Google Scholar
• Dworkin RH, White R, O’Connor AB, et al. Healthcare costs of acute and chronic pain associated with a diagnosis of herpes zoster. J Am Geriatr Soc 2007;55:1168-75
   PubMed Web of Science ®Google Scholar